Compile Data Set for Download or QSAR
Report error Found 57 Enz. Inhib. hit(s) with Target = 'Mitogen-activated protein kinase 14/MAP kinase-activated protein kinase 5'
LigandPNGBDBM606260(US11685719, Example 27A | US11685719, Example 27B)
Affinity DataIC50: 794nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606209(US11685719, Example 2A | US11685719, Example 2B)
Affinity DataIC50: 1.26E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606215(US11685719, Example 5A | US11685719, Example 5B | ...)
Affinity DataIC50: 1.59E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606222(US11685719, Example 9A | US11685719, Example 9B)
Affinity DataIC50: 2.00E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606236(US11685719, Example 15A | US11685719, Example 15B)
Affinity DataIC50: 2.51E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606220(US11685719, Example 8A | US11685719, Example 8B)
Affinity DataIC50: 2.51E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606215(US11685719, Example 5A | US11685719, Example 5B | ...)
Affinity DataIC50: 2.51E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606246(US11685719, Example 20A | US11685719, Example 20B)
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606233(US11685719, Example 14B | US11685719, Example 14D)
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606232(US11685719, Example 14A | US11685719, Example 14C)
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606262(US11685719, Example 28A | US11685719, Example 28B)
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606258(US11685719, Example 26A | US11685719, Example 26B)
Affinity DataIC50: 3.16E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606224(US11685719, Example 10A | US11685719, Example 10B)
Affinity DataIC50: 3.98E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50: 3.98E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606226(US11685719, Example 11A | US11685719, Example 11B)
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606211(US11685719, Example 3A | US11685719, Example 3B)
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606213(US11685719, Example 4A | US11685719, Example 21A |...)
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606213(US11685719, Example 4A | US11685719, Example 21A |...)
Affinity DataIC50: 5.01E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606218(US11685719, Example 7A | US11685719, Example 23A |...)
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606256(US11685719, Example 25A | US11685719, Example 25B)
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606217(US11685719, Example 6)
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606240(US11685719, Example 17A | US11685719, Example 17B)
Affinity DataIC50: 6.31E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606238(US11685719, Example 16A | US11685719, Example 16B)
Affinity DataIC50: 7.94E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606218(US11685719, Example 7A | US11685719, Example 23A |...)
Affinity DataIC50: 7.94E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606228(US11685719, Example 12A | US11685719, Example 12B)
Affinity DataIC50: 7.94E+3nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606230(US11685719, Example 13A | US11685719, Example 13B)
Affinity DataIC50: 1.58E+4nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606233(US11685719, Example 14B | US11685719, Example 14D)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606230(US11685719, Example 13A | US11685719, Example 13B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606228(US11685719, Example 12A | US11685719, Example 12B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606213(US11685719, Example 4A | US11685719, Example 21A |...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606232(US11685719, Example 14A | US11685719, Example 14C)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606222(US11685719, Example 9A | US11685719, Example 9B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606236(US11685719, Example 15A | US11685719, Example 15B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606238(US11685719, Example 16A | US11685719, Example 16B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606240(US11685719, Example 17A | US11685719, Example 17B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606246(US11685719, Example 20A | US11685719, Example 20B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606207(US11685719, Example 1A | US11685719, Example 1B | ...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606215(US11685719, Example 5A | US11685719, Example 5B | ...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606226(US11685719, Example 11A | US11685719, Example 11B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606224(US11685719, Example 10A | US11685719, Example 10B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606250(US11685719, Example 22A | US11685719, Example 22B ...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606220(US11685719, Example 8A | US11685719, Example 8B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606218(US11685719, Example 7A | US11685719, Example 23A |...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606215(US11685719, Example 5A | US11685719, Example 5B | ...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606218(US11685719, Example 7A | US11685719, Example 23A |...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606213(US11685719, Example 4A | US11685719, Example 21A |...)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM606211(US11685719, Example 3A | US11685719, Example 3B)
Affinity DataIC50: 3.16E+5nMAssay Description:A typical assay was conducted in 20 μL volume including 60 μM active p38α (Carna, cat #04-152), 10 μM ATP, 1 μM FITC-HSP27 p...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: